Waters Corporation (WAT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-04..
Quick ratio
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-04. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.40B USD | Liabilities, Current |
| Cash and equivalents | 539.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.99B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 1.38B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-04 | (m) | $2.40B | $539.00M | (m) | $1.99B | $1.38B | (m) |
| 2026-04-04 | (m) | $2.27B | $462.00M | (m) | $1.75B | $1.50B | (m) |
| 2025-12-31 | (m) | $1.24B | $587.83M | (m) | $828.84M | $572.37M | (m) |
| 2025-09-27 | (m) | $1.25B | $459.12M | (m) | $748.52M | $572.94M | (m) |
| 2025-06-28 | (m) | $1.02B | $367.21M | (m) | $730.07M | $540.75M | (m) |
| 2025-03-29 | (m) | $960.97M | $382.87M | (m) | $713.28M | $511.50M | (m) |
| 2024-12-31 | (m) | $789.76M | $324.42M | (m) | $733.37M | $477.26M | (m) |
| 2024-09-28 | (m) | $816.04M | $330.51M | (m) | $669.53M | $518.99M | (m) |
| 2024-06-29 | (m) | $762.53M | $326.43M | (m) | $610.09M | $522.93M | (m) |
| 2024-03-30 | (m) | $848.46M | $337.29M | (m) | $626.33M | $538.63M | (m) |
| 2023-12-31 | (m) | $789.58M | $395.08M | (m) | $702.17M | $516.24M | (m) |
| 2023-09-30 | (m) | $745.03M | $336.41M | (m) | $631.28M | $544.40M | (m) |
| 2023-07-01 | (m) | $809.39M | $329.69M | (m) | $693.44M | $536.83M | (m) |
| 2023-04-01 | (m) | $801.95M | $486.07M | (m) | $683.34M | $499.42M | (m) |
| 2022-12-31 | (m) | $785.74M | $480.53M | (m) | $722.89M | $455.71M | (m) |
| 2022-10-01 | (m) | $731.97M | $443.64M | (m) | $600.92M | $442.24M | (m) |
| 2022-07-02 | (m) | $746.56M | $418.90M | (m) | $639.45M | $409.92M | (m) |
| 2022-04-02 | (m) | $687.83M | $480.07M | (m) | $607.26M | $381.90M | (m) |
| 2021-12-31 | (m) | $680.51M | $501.23M | (m) | $612.65M | $356.10M | (m) |
| 2021-10-02 | (m) | $671.89M | $524.70M | (m) | $532.96M | $388.76M | (m) |
| 2021-07-03 | (m) | $681.02M | $460.06M | (m) | $543.07M | $348.77M | (m) |
| 2021-04-03 | (m) | $785.05M | $683.78M | (m) | $550.68M | $327.97M | (m) |
| 2020-12-31 | (m) | $804.98M | $436.69M | (m) | $573.32M | $304.28M | (m) |
| 2020-09-26 | (m) | $722.19M | $374.93M | (m) | $494.43M | $326.95M | (m) |
| 2020-06-27 | (m) | $697.32M | $339.04M | (m) | $496.28M | $344.01M | (m) |
| 2020-03-28 | (m) | $551.05M | $390.06M | (m) | $522.21M | $344.01M | (m) |
| 2019-12-31 | (m) | $591.33M | $335.71M | (m) | $587.73M | $320.55M | (m) |
| 2019-09-28 | (m) | $597.15M | $404.65M | (m) | $504.87M | $368.79M | (m) |
| 2019-06-29 | (m) | $611.70M | $588.00M | (m) | $518.52M | $351.55M | (m) |
| 2019-03-30 | (m) | $603.28M | $684.97M | (m) | $508.29M | $333.31M | (m) |
| 2018-12-31 | (m) | $448.93M | $796.28M | (m) | $568.32M | $291.57M | (m) |
| 2018-09-29 | (m) | $448.13M | $689.37M | (m) | $489.19M | $313.61M | (m) |
| 2018-06-30 | (m) | $474.92M | $742.20M | (m) | $492.83M | $299.60M | (m) |
| 2018-03-31 | (m) | $534.35M | $716.52M | (m) | $502.97M | $299.61M | (m) |
| 2017-12-31 | (m) | $606.16M | $642.32M | (m) | $533.83M | $270.29M | (m) |
| 2017-09-30 | (m) | $662.15M | $603.81M | (m) | $456.33M | $297.85M | (m) |
| 2017-07-01 | (m) | $653.29M | $567.25M | (m) | $462.81M | $287.14M | (m) |
| 2017-04-01 | (m) | $632.21M | $584.44M | (m) | $461.75M | $279.98M | (m) |
| 2016-12-31 | (m) | $520.32M | $505.63M | (m) | $489.34M | $262.68M | (m) |
| 2016-10-01 | (m) | $519.50M | $430.21M | (m) | $441.77M | $303.18M | (m) |
| 2016-07-02 | (m) | $522.60M | $463.38M | (m) | $445.95M | $286.45M | (m) |
| 2016-04-02 | (m) | $524.03M | $416.39M | (m) | $439.58M | $287.05M | (m) |
| 2015-12-31 | (m) | $564.08M | $487.67M | (m) | $468.31M | $263.42M | (m) |
| 2015-10-03 | (m) | $535.95M | $459.52M | (m) | $416.31M | $281.79M | (m) |
| 2015-07-04 | (m) | $546.69M | $365.88M | (m) | $406.58M | $272.93M | (m) |
| 2015-04-04 | (m) | $538.47M | $440.80M | (m) | $394.37M | $257.53M | (m) |
| 2014-12-31 | (m) | $581.60M | $422.18M | (m) | $433.62M | $246.43M | (m) |
| 2014-09-27 | (m) | $574.48M | $356.97M | (m) | $393.17M | $269.10M | (m) |
| 2014-06-28 | (m) | $594.59M | $428.69M | (m) | $401.92M | $272.76M | (m) |
| 2014-03-29 | (m) | $584.45M | $395.38M | (m) | $401.41M | $266.63M | (m) |
| 2013-12-31 | (m) | $487.53M | $440.80M | (m) | $430.99M | $242.80M | (m) |
| 2013-09-28 | (m) | $492.90M | $431.00M | (m) | $373.84M | $256.98M | (m) |
| 2013-06-29 | (m) | $474.95M | $455.05M | (m) | $365.22M | $242.64M | (m) |
| 2013-03-30 | (m) | $476.87M | $472.05M | (m) | $377.41M | $235.88M | (m) |
| 2012-12-31 | (m) | $504.24M | $481.04M | (m) | $404.56M | $229.56M | (m) |
| 2012-09-29 | (m) | $767.56M | $356.29M | (m) | $362.37M | $246.99M | (m) |
| 2012-06-30 | (m) | $721.66M | $369.43M | (m) | $355.14M | $236.76M | (m) |
| 2012-03-31 | (m) | $648.28M | $427.19M | (m) | $353.75M | $233.36M | (m) |
| 2011-12-31 | (m) | $601.86M | $383.99M | (m) | $367.08M | $212.86M | (m) |
| 2011-10-01 | (m) | $605.58M | $423.93M | (m) | $354.44M | $246.26M | (m) |
| 2011-07-02 | (m) | $467.30M | $344.91M | (m) | $365.33M | $243.18M | (m) |
| 2011-04-02 | (m) | $716.23M | $296.86M | (m) | $349.40M | $223.88M | (m) |
| 2010-12-31 | (m) | $385.85M | $308.50M | (m) | $358.24M | $204.30M | (m) |
| 2010-10-02 | (m) | $417.41M | $262.79M | (m) | $337.56M | $208.34M | (m) |
| 2010-07-03 | (m) | $362.57M | $310.88M | (m) | $314.17M | $191.78M | (m) |
| 2010-04-03 | (m) | $305.20M | $297.01M | (m) | $313.95M | $189.22M | (m) |
| 2009-12-31 | (m) | $394.57M | $341.11M | (m) | $314.25M | $178.67M | (m) |
| 2009-10-03 | (m) | $432.21M | $390.42M | (m) | $289.65M | $197.09M | (m) |
| 2009-07-04 | (m) | $400.10M | $358.44M | (m) | $294.94M | $196.32M | (m) |
| 2009-04-04 | (m) | (m) | $388.15M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $289.51M | $428.52M | (m) | $291.76M | $173.05M | (m) |
| 2008-09-27 | (m) | (m) | $892.60M | (m) | (m) | (m) | (m) |
| 2008-06-28 | (m) | (m) | $830.68M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $597.33M | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $514.17M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |